Simon Quick Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $609K | Buy |
8,720
+751
| +9% | +$52.5K | 0.02% | 373 |
|
|
2025
Q1 | $586K | Buy |
7,969
+2,390
| +43% | +$176K | 0.03% | 262 |
|
|
2024
Q4 | $366K | Sell |
5,579
-775
| -12% | -$50.8K | 0.02% | 317 |
|
|
2024
Q3 | $495K | Buy |
6,354
+192
| +3% | +$15K | 0.03% | 243 |
|
|
2024
Q2 | $481K | Buy |
6,162
+1,560
| +34% | +$122K | 0.03% | 225 |
|
|
2024
Q1 | $312K | Buy |
4,602
+286
| +7% | +$19.4K | 0.02% | 283 |
|
|
2023
Q4 | $291K | Sell |
4,316
-41
| -0.9% | -$2.76K | 0.03% | 245 |
|
|
2023
Q3 | $295K | Sell |
4,357
-497
| -10% | -$33.7K | 0.03% | 237 |
|
|
2023
Q2 | $347K | Buy |
4,854
+758
| +19% | +$54.3K | 0.03% | 193 |
|
|
2023
Q1 | $284K | Buy |
4,096
+692
| +20% | +$48K | 0.03% | 218 |
|
|
2022
Q4 | $231K | Buy |
+3,404
| New | +$231K | 0.03% | 211 |
|
|
2021
Q2 | – | Sell |
-102
| Closed | -$5K | – | 443 |
|
|
2021
Q1 | $5K | Buy |
102
+2
| +2% | +$98 | ﹤0.01% | 413 |
|
|
2020
Q4 | $5K | Sell |
100
-442
| -82% | -$22.1K | ﹤0.01% | 397 |
|
|
2020
Q3 | $30K | Buy |
+542
| New | +$30K | 0.01% | 265 |
|
|
2020
Q1 | – | Sell |
-969
| Closed | -$48K | – | 492 |
|
|
2019
Q4 | $48K | Buy |
969
+909
| +1,515% | +$45K | 0.02% | 227 |
|
|
2019
Q3 | $3K | Hold |
60
| – | – | ﹤0.01% | 329 |
|
|
2019
Q2 | $2.48K | Buy |
+60
| New | +$2.48K | ﹤0.01% | 348 |
|
|
2018
Q1 | – | Sell |
-150
| Closed | -$5K | – | 318 |
|
|
2017
Q4 | $5K | Buy |
+150
| New | +$5K | ﹤0.01% | 362 |
|